Indolyl derivatives substituted with a thiazole ring and their use as PPAR modulators

Details for Australian Patent Application No. 2004255580 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Maerki, Hans-Peter; Hirth, Georges; Aebi, Johannes; Wright, Matthew Blake; Grether, Uwe; Kuhn, Bernd; Meyer, Markus; Ackermann, Jean; Mohr, Peter; Binggeli, Alfred

Agent Spruson & Ferguson

Pub. Number AU-B-2004255580

PCT Pub. Number WO2005/005423

Priority 04100157.9 20.01.04 EP; 03014476.0 02.07.03 EP

Filing date 25 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 8 October 2009

International Classifications

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005423 Priority application(s): WO2005/005423

8 October 2009 Application Accepted

  Published as AU-B-2004255580

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255581-Arylamine-substituted quinazolinone compounds

2004255575-Device and method for processing packages which are continuously prepared on carrier elements